Ionis Pharmaceuticals IONS Capital And Patent Expenditures Incurred But Not Yet Paid
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:CapitalAndPatentExpendituresIncurredButNotYetPaid.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's capital and patent expenditures incurred but not yet paid.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's capital and patent expenditures incurred but not yet paid?
- Ionis Pharmaceuticals (IONS) reported capital and patent expenditures incurred but not yet paid of $1.04M in Q1 2026.
- How has Ionis Pharmaceuticals's capital and patent expenditures incurred but not yet paid changed year-over-year?
- Ionis Pharmaceuticals's capital and patent expenditures incurred but not yet paid increased by 126.7% year-over-year, from $460K to $1.04M.